Response to oral steroids for sudden sensorineural hearing loss: considerations of age, time to treatment, and degree of hearing loss
Audiology and Neurotology · 2025
DOI: 10.1159/000545672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Audiology and Neurotology, 2025. Verfasst von Erin Harvey und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Hearing Loss, Sudden, Hearing Loss, Sensorineural, Glucocorticoids, Time-to-Treatment.
Abstract (Originalsprache)
Introduction
Compare outcomes of oral steroids (OS) to intratympanic (IT) steroids for treatment of idiopathic sudden sensorineural hearing loss (ISSNHL) in a retrospective cohort study at a tertiary academic center.
Methods
Patients diagnosed with ISSNHL receiving at least one course of OS between January 2009 and February 2022 were reviewed. OS patients were compared to a previously reported cohort of 74 patients who underwent IT treatment.
Interventions
OS or IT steroid therapy for ISSNHL. Full, partial or no recovery rates of hearing thresholds stratified by modality of treatment, age, degree of hearing loss, and time to initiation of treatment were measured.
Results
There were 96 patients treated with OS and 74 patients treated with IT steroid. Full recovery was more frequent in patients who underwent oral steroid therapy (43.8%) compared to IT therapy (25.68%, p=0.017). For patients under 40 years old, full recovery rates were similar between OS (60.0%) and IT (61.5%). In patients over 40 years old, however, full recovery was seen in 40.7% of patients on OS and 18% for IT. Further, while those over 65 years had the worst rates of full recovery to IT steroid (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Department of Otolaryngology, University of Missouri, Columbia, Missouri, USA.
- Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA, dfriedland@mcw.edu.
- Clinical and Translational Science Institute Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Department of Health Informatics and Administration, University of Wisconsin - Milwaukee, Milwaukee, Wisconsin, USA.
Zitieren
APA
Harvey, E., Callan, G., Osafo, N., Friedland, D., Harris, M. S., Adams, J., Osinski, K., Tong, L., & Luo, J. (2025). Response to oral steroids for sudden sensorineural hearing loss: considerations of age, time to treatment, and degree of hearing loss. Audiology and Neurotology. https://doi.org/10.1159/000545672
Vancouver
Harvey E, Callan G, Osafo N, Friedland D, Harris MS, Adams J, et al. Response to oral steroids for sudden sensorineural hearing loss: considerations of age, time to treatment, and degree of hearing loss. Audiology and Neurotology. 2025. doi:10.1159/000545672
BibTeX
@article{Harvey2025,
author = {Harvey, Erin and Callan, Grace and Osafo, Neil and Friedland, David and Harris, Michael S and Adams, Jazzmyne and Osinski, Kristen and Tong, Ling and Luo, Jake},
title = {Response to oral steroids for sudden sensorineural hearing loss: considerations of age, time to treatment, and degree of hearing loss},
journal = {Audiology and Neurotology},
year = {2025},
doi = {10.1159/000545672}
}
EUVIMED